PubMedCrossRef 3 Zou W: Regulatory T cells, tumour immunity and

PubMedCrossRef 3. Zou W: Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006, 6:295–307.PubMedCrossRef 4. Huang FP, Chen YX, To CK: Guiding the “”misguided”" – functional conditioning

of dendritic cells for the DC-based immunotherapy against tumours. Eur J Immunol 2011, 41:18–25.PubMedCrossRef 5. Sabat R, Grutz G, Warszawska K, Kirsch 17DMAG in vivo S, Witte E, Wolk K, Geginat J: Biology of interleukin-10. Cytokine Growth Factor Rev 2010, 21:331–344.PubMedCrossRef 6. Steinbrink K, Jonuleit H, Muller G, Schuler G, Knop J, Enk AH: Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 1999, 93:1634–1642.PubMed 7. Yang L: TGFbeta, a potent regulator of tumor microenvironment and host immune response, implication for therapy. Curr Mol Med 2010, 10:374–380.PubMedCrossRef 8. Geissmann F, Revy P, Regnault A, Lepelletier Y, Dy M, Brousse N, C188-9 mw Amigorena S, Hermine O, Durandy A: SCH772984 in vitro TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J Immunol 1999, 162:4567–4575.PubMed 9. Johnson BF, Clay TM, Hobeika AC, Lyerly HK, Morse

MA: Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy. Expert Opin Biol Ther 2007, 7:449–460.PubMedCrossRef 10. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996, 2:1096–1103.PubMedCrossRef 11. Gabrilovich D: Mechanisms and functional Enzalutamide manufacturer significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 2004, 4:941–952.PubMedCrossRef 12. Martin F, Chan AC: B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol 2006, 24:467–496.PubMedCrossRef 13. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ: A novel mouse with B cells but lacking serum antibody reveals an antibody-independent

role for B cells in murine lupus. J Exp Med 1999, 189:1639–1648.PubMedCrossRef 14. Kleindienst P, Brocker T: Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo. Immunology 2005, 115:556–564.PubMedCrossRef 15. Yan J, Harvey BP, Gee RJ, Shlomchik MJ, Mamula MJ: B cells drive early T cell autoimmunity in vivo prior to dendritic cell-mediated autoantigen presentation. J Immunol 2006, 177:4481–4487.PubMed 16. Shimabukuro-Vornhagen A, Hallek MJ, Storb RF, von Bergwelt-Baildon MS: The role of B cells in the pathogenesis of graft-versus-host disease. Blood 2009, 114:4919–4927.PubMedCrossRef 17. Constant S, Schweitzer N, West J, Ranney P, Bottomly K: B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol 1995, 155:3734–3741.PubMed 18.

Comments are closed.